StockData
Biodexa Pharmaceuticals Plc logo

Biodexa Pharmaceuticals Plc (BDRX) stock

BDRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 27, 2026Score 1/30
$2.04−0.10 (-4.89%)

Close on Nov 18, 2026Market cap $4.60MP/E –Yield –

Biodexa Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Biodexa Pharmaceuticals's price to sales ratio was 8.8× on Feb 28, 2025, against 0.7× a year earlier. Over the last 5 years it ranged from 0.7× to 490.2×, with a median of 71.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Feb 28, 20258.8×−2.0
2024Dec 31, 202410.7×+9.2
2023Dec 29, 20231.5×−336.2
2021Jan 29, 2021337.7×+39.9
2020Dec 31, 2020297.8×+265.0
2019Dec 31, 201932.8×−93.3
2018Dec 31, 2018126.0×−211.5
2017Dec 29, 2017337.6×–

More Biodexa Pharmaceuticals figures

See a number that looks wrong?